Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bobby Gaspar
CEO | Chief Executive Officer | 60 | 14-12-31 |
Frank Thomas
PSD | President | 54 | 17-12-31 |
Leslie Meltzer
CTO | Chief Tech/Sci/R&D Officer | - | 18-05-31 |
Nicoletta Loggia
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-08 |
Fulvio Mavilio
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Renee T. Leck
IRC | Investor Relations Contact | - | - |
Christopher York
SEC | Corporate Secretary | - | - |
Braden Parker
PRN | Corporate Officer/Principal | - | - |
John Cerio
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Abdul Mullick
BRD | Director/Board Member | - | Jan. 23 |
Yasuo Fujii
BRD | Director/Board Member | - | Jan. 23 |
60 | - | ||
Director/Board Member | 62 | Jan. 23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,572,749 | 81,786,701 ( 64.62 %) | 0 | 64.62 % |
Company contact information
Orchard Therapeutics Plc
245 Hammersmith Road 3rd Floor
W6 8PW, London
+44 20 3 808 8286
http://www.orchard-tx.comSector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |